Evaluating strategic options for iopofosine I 131 a late-stage clinical program with compelling Phase 2 data and a substantial market ...
Anixa's focus on breast and ovarian cancer immunotherapies shows promise but lacks substantial data. Find out why I ...
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the ...
Discover key challenges in clinical trial design and learn how the right software can significantly boost the likelihood of ...
Thirty years after the sequencing of the BRCA1 cancer-associated gene, access to genetic tests and awareness about its risks ...
Research and development (R&D) activities are anticipated to drive growth in the adenosine antagonists market by identifying novel therapeutic applications, such as in neurodegenerative diseases, ...
The Amyloidosis market was $3.6 billion in 2017, and is expected to reach $6 billion in 2025, according to Grand View Research.
Traumatic brain injury (TBI) is a leading cause of death and disability among young people in the United States and is the most devastating survivable injury in modern warfare, according to the ...
ENERGIZE-T Study Achieved Primary and All Key Secondary Endpoints in Adult Patients with Transfusion-Dependent Alpha- or Beta-Thalassemia –– ...